Mike Rabe

ChemGenex: A Snow-Fueled Setback at the FDA

ODAC meeting was rescheduled for March 22nd.

Biomoda (BMOD.OTC) Currently Flying Under the Radar

Thanks, Roy. Huge coverage on BioMedReports.com yesterday as they posted my article.

I'm sorry SeekingAlpha did not turn my blog piece into an article so you were one of the few that probably found out about it.

I'll have some other big winners in 2010 for sure. Stay tuned.

Hana Biosciences (HNAB) set for a major comeback

The stock was over $11 a few years ago. What accounted for the huge dropoff to the pennies?

3 Holiday Stocking Stuffers for Big Gains in 2010

Folks, take a serious look at Chemgenex. It is running hard in Australia (CXS.AX) and has yet to run on the American ADR (CXSPY).

Golden opportunity here to pick up more shares on the ADR. Good luck to all of you.

E*Trade: Expect a Takeover Any Day Now

Etrade has by far the best trading platform. I have accounts in both Etrade and Ameritrade.

I give Ameritrade very low marks and I pray they don't acquire Etrade.

There is no comparison between Etrade and Ameritrade.

Finally, for those who bash Etrade's customer service, I have talked with customer service reps there probably over 200 times in the past 6 years. I have had 2 bad experiences. That's 2 out of 200.

Clinuvel Pharmaceuticals: Key Catalysts Imminent

Hi David -

Clinuvel has plenty of cash, which is critical in such an economic time of uncertainty.

Keep an eye out for the preliminary EPP Phase III results which should be reported soon. If the data looks good, you should see some movement in the share price.

CUV (on the ASX) is being held down at .335, and has been since mid-June. Watch for a break beyond that resistance.

Lots of news will be reported in Q4 2009. This will be a major quarter for the company. We will have a much clearer idea of things after the coming quarter. But if you want in the stock, now is the time as any unexpected good news will ignite it.